Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancer (Q39140763)
Jump to navigation
Jump to search
scientific article published on 11 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancer |
scientific article published on 11 June 2013 |
Statements
1 reference
Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancer (English)
1 reference
Anna Spreafico
1 reference
John J Tentler
1 reference
Todd M Pitts
1 reference
Aik Choon Tan
1 reference
Mark A Gregory
1 reference
John J Arcaroli
1 reference
Peter J Klauck
1 reference
Martine C McManus
1 reference
Ryan J Hansen
1 reference
Jihye Kim
1 reference
Lindsey N Micel
1 reference
Heather M Selby
1 reference
Timothy P Newton
1 reference
Kelly L McPhillips
1 reference
Daniel L Gustafson
1 reference
James V Degregori
1 reference
Wells A Messersmith
1 reference
Robert A Winn
1 reference
S Gail Eckhardt
1 reference
11 June 2013
1 reference
1 reference
19
1 reference
15
1 reference
4149-4162
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference